A federal judge struck down New York State's newly enacted opioid tax, creating a potential budgetary challenge as Gov. Andrew Cuomo gears up to unveil his next fiscal plan.
U.S. District Court Judge Katherine Polk Failla granted an injunction in a Dec. 19
“The OSA is not a tax, but is rather a regulatory penalty on opioid manufacturers and distributors,” Judge Failla wrote in her 52-page decision. “As currently structured, it improperly burdens interstate commerce.”
Failla called New York’s goals under the OSA “commendable”, but said the state’s pursuit of improving public health cannot violate the Commerce Clause of the U.S. Constitution. She added that a “perhaps unforeseen consequence” of the tax would be reducing availability of opioid medications for those most in need of them as a result of higher prices.
The lawsuit was filed by the Healthcare Distribution Alliance with the Association for Accessible Medicines and SpecGx LLC later joining the suit. The New York Office of the Attorney General and Department of Health, which were named in the lawsuit, did not immediately respond for comment on if the state planned to appeal the ruling.
Judge Failla’s decision could impact other states weighing similar opioid tax measures. Kentucky lawmakers
This month, Cuomo is slated to unveil his budget proposal for the 2020 fiscal year that commences April 1. The Democratic governor is beginning his third term with his party in control of both chambers of the state legislature after
The Empire State has general obligation ratings of Aa1 by Moody's Investors Service, and AA-plus by S&P Global Ratings, Fitch Ratings and Kroll Bond Rating Agency.